Emerging evidence suggests that sustained activation of JNK-c-Jun signaling is oncogenic in lung cancer, leading to promotion of tumor cell proliferation and survival ability, and to neoplastic transformation of bronchial epithelial cell lines [25–27]. Here, MAPK8 is linked to lung cancer.